Table of Content

1. Executive Summary
   1.1. Global Human Insulin Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overviews
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
       2.3.3. Global Healthcare Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Drug Adoption Analysis
   3.2. Value Chain Analysis
       3.2.1. List of End-user/Marketplaces
           3.2.1.1. Retail
           3.2.1.2. E-Commerce
       3.2.2. List of End User (Industry)
   3.3. Key Deals and Mergers
   3.4. PESTLE Analysis
   3.5. Porter’s Five Force Analysis
4. Global Human Insulin Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Bn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
       4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024-2031
   4.3. Global Human Insulin Market Outlook: Type
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Bn) Analysis, By Type, 2019 - 2023
       4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024 - 2031
           4.3.3.1. Modern Human Insulin
               4.3.3.1.1. Fast-acting
               4.3.3.1.2. Long-acting
               4.3.3.1.3. Premix
           4.3.3.2. Traditional Human Insulin
               4.3.3.2.1. Long-acting
               4.3.3.2.2. Short-acting
               4.3.3.2.3. Fast-acting
               4.3.3.2.4. Premix
       4.3.4. Market Attractiveness Analysis: Type
   4.4. Global Human Insulin Market Outlook: Type of Diabetes
       4.4.1. Introduction / Key Findings
       4.4.2. Historical Market Size (US$ Bn) Analysis, By Type of Diabetes, 2019 - 2023
       4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Diabetes, 2024 - 2031
           4.4.3.1. Diabetes Type 1
           4.4.3.2. Diabetes Type 2
       4.4.4. Market Attractiveness Analysis: Type of Diabetes
   4.5. Global Human Insulin Market Outlook: Distribution Channel
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019 - 2023
       4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024 - 2031
           4.5.3.1. Retail Pharmacies
           4.5.3.2. Hospital Pharmacies
           4.5.3.3. Online Pharmacies
       4.5.4. Market Attractiveness Analysis: Distribution Channel
5. Global Human Insulin Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
   5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024 - 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Human Insulin Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       6.2.1. By Country
       6.2.2. By Type
       6.2.3. By Type of Diabetes
       6.2.4. By Distribution Channel
   6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
       6.3.1. U.S.
       6.3.2. Canada
   6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024 - 2031
       6.4.1. Modern Human Insulin
           6.4.1.1. Fast-acting
           6.4.1.2. Long-acting
           6.4.1.3. Premix
       6.4.2. Traditional Human Insulin
           6.4.2.1. Long-acting
           6.4.2.2. Short-acting
           6.4.2.3. Fast-acting
           6.4.2.4. Premix
   6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Diabetes, 2024 - 2031
       6.5.1. Diabetes Type 1
       6.5.2. Diabetes Type 2
   6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024 - 2031
       6.6.1. Retail Pharmacies
       6.6.2. Hospital Pharmacies
       6.6.3. Online Pharmacies
   6.7. Market Attractiveness Analysis
7. Europe Human Insulin Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   7.1. Key Highlights
   7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       7.2.1. By Country
       7.2.2. By Type
       7.2.3. By Type of Diabetes
       7.2.4. By Distribution Channel
   7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
       7.3.1. Germany
       7.3.2. France
       7.3.3. U.K.
       7.3.4. Italy
       7.3.5. Spain
       7.3.6. Russia
       7.3.7. Türkiye
       7.3.8. Rest of Europe
   7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024 - 2031
       7.4.1. Modern Human Insulin
           7.4.1.1. Fast-acting
           7.4.1.2. Long-acting
           7.4.1.3. Premix
       7.4.2. Traditional Human Insulin
           7.4.2.1. Long-acting
           7.4.2.2. Short-acting
           7.4.2.3. Fast-acting
           7.4.2.4. Premix
   7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Diabetes, 2024 - 2031
       7.5.1. Diabetes Type 1
       7.5.2. Diabetes Type 2
   7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024 - 2031
       7.6.1. Retail Pharmacies
       7.6.2. Hospital Pharmacies
       7.6.3. Online Pharmacies
   7.7. Market Attractiveness Analysis
8. East Asia Human Insulin Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   8.1. Key Highlights
   8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       8.2.1. By Country
       8.2.2. By Type
       8.2.3. By Type of Diabetes
       8.2.4. By Distribution Channel
   8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
       8.3.1. China
       8.3.2. Japan
       8.3.3. South Korea
   8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024 - 2031
       8.4.1. Modern Human Insulin
           8.4.1.1. Fast-acting
           8.4.1.2. Long-acting
           8.4.1.3. Premix
       8.4.2. Traditional Human Insulin
           8.4.2.1. Long-acting
           8.4.2.2. Short-acting
           8.4.2.3. Fast-acting
           8.4.2.4. Premix
   8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Diabetes, 2024 - 2031
       8.5.1. Diabetes Type 1
       8.5.2. Diabetes Type 2
   8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024 - 2031
       8.6.1. Retail Pharmacies
       8.6.2. Hospital Pharmacies
       8.6.3. Online Pharmacies
   8.7. Market Attractiveness Analysis
9. South Asia and Oceania Human Insulin Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   9.1. Key Highlights
   9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       9.2.1. By Country
       9.2.2. By Type
       9.2.3. By Type of Diabetes
       9.2.4. By Distribution Channel
   9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
       9.3.1. India
       9.3.2. Southeast Asia
       9.3.3. ANZ
       9.3.4. Rest of South Asia & Oceania
   9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024 - 2031
       9.4.1. Modern Human Insulin
           9.4.1.1. Fast-acting
           9.4.1.2. Long-acting
           9.4.1.3. Premix
       9.4.2. Traditional Human Insulin
           9.4.2.1. Long-acting
           9.4.2.2. Short-acting
           9.4.2.3. Fast-acting
           9.4.2.4. Premix
   9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Diabetes, 2024 - 2031
       9.5.1. Diabetes Type 1
       9.5.2. Diabetes Type 2
   9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024 - 2031
       9.6.1. Retail Pharmacies
       9.6.2. Hospital Pharmacies
       9.6.3. Online Pharmacies
   9.7. Market Attractiveness Analysis
10. Latin America Human Insulin Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   10.1. Key Highlights
   10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       10.2.1. By Country
       10.2.2. By Type
       10.2.3. By Type of Diabetes
       10.2.4. By Distribution Channel
   10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
       10.3.1. Brazil
       10.3.2. Mexico
       10.3.3. Rest of Latin America
   10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024 - 2031
       10.4.1. Modern Human Insulin
           10.4.1.1. Fast-acting
           10.4.1.2. Long-acting
           10.4.1.3. Premix
       10.4.2. Traditional Human Insulin
           10.4.2.1. Long-acting
           10.4.2.2. Short-acting
           10.4.2.3. Fast-acting
           10.4.2.4. Premix
   10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Diabetes, 2024 - 2031
       10.5.1. Diabetes Type 1
       10.5.2. Diabetes Type 2
   10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024 - 2031
       10.6.1. Retail Pharmacies
       10.6.2. Hospital Pharmacies
       10.6.3. Online Pharmacies
   10.7. Market Attractiveness Analysis
11. Middle East & Africa Human Insulin Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   11.1. Key Highlights
   11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       11.2.1. By Country
       11.2.2. By Type
       11.2.3. By Type of Diabetes
       11.2.4. By Distribution Channel
   11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
       11.3.1. GCC Countries
       11.3.2. Egypt
       11.3.3. South Africa
       11.3.4. Northern Africa
       11.3.5. Rest of Middle East & Africa
   11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2024 - 2031
       11.4.1. Modern Human Insulin
           11.4.1.1. Fast-acting
           11.4.1.2. Long-acting
           11.4.1.3. Premix
       11.4.2. Traditional Human Insulin
           11.4.2.1. Long-acting
           11.4.2.2. Short-acting
           11.4.2.3. Fast-acting
           11.4.2.4. Premix
   11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Diabetes, 2024 - 2031
       11.5.1. Diabetes Type 1
       11.5.2. Diabetes Type 2
   11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2024 - 2031
       11.6.1. Retail Pharmacies
       11.6.2. Hospital Pharmacies
       11.6.3. Online Pharmacies
   11.7. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Novo Nordisk A/S.
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. Eli Lilly and Company.
       12.3.3. Sanofi.
       12.3.4. Biocon.
       12.3.5. Tonghua Dongbao Pharmaceutical Co., Ltd.
       12.3.6. Adocia
       12.3.7. Merck & Co., Inc.
       12.3.8. Pfizer, Inc.
       12.3.9. Wockhardt.
       12.3.10. Julphar
       12.3.11. Bristol-Myers Squibb Company.
       12.3.12. GlaxoSmithKline Plc.
       12.3.13. Oramed Pharmaceuticals, Inc.
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations